Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26:4124–30. https://doi.org/10.1200/jco.2008.16.4558.

Article  Google Scholar 

Mourad N, Mounier N, Brière J, Raffoux E, Delmer A, Feller A, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood. 2008;111:4463–70. https://doi.org/10.1182/blood-2007-08-105759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol: Off J Am Soc Clin Oncol. 2013;31:240–6. https://doi.org/10.1200/jco.2011.37.3647.

Article  CAS  Google Scholar 

Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007;31:1077–88. https://doi.org/10.1097/PAS.0b013e31802d68e9.

Article  PubMed  Google Scholar 

de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109:4952–63. https://doi.org/10.1182/blood-2006-10-055145.

Article  CAS  PubMed  Google Scholar 

Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S, et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res. 2007;67:10703–10. https://doi.org/10.1158/0008-5472.Can-07-1708.

Article  CAS  PubMed  Google Scholar 

Cortes JR, Ambesi-Impiombato A, Couronné L, Quinn SA, Kim CS, da Silva Almeida AC, et al. RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis. Cancer Cell. 2018;33:259–.e257. https://doi.org/10.1016/j.ccell.2018.01.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020;34:2592–606. https://doi.org/10.1038/s41375-020-0990-y.

Article  PubMed  PubMed Central  Google Scholar 

Mondragón L, Mhaidly R, De Donatis GM, Tosolini M, Dao P, Martin AR, et al. GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-κB-dependent mechanism. Cancer Cell. 2019;36:268–.e210. https://doi.org/10.1016/j.ccell.2019.07.008.

Article  CAS  PubMed  Google Scholar 

Shi J, Hou S, Fang Q, Liu X, Liu X, Qi H. PD-1 controls follicular T helper cell positioning and function. Immunity. 2018;49:264–.e264. https://doi.org/10.1016/j.immuni.2018.06.012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123:1293–6. https://doi.org/10.1182/blood-2013-10-531509.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:171–5. https://doi.org/10.1038/ng.2872.

Article  CAS  PubMed  Google Scholar 

Palomero T, Couronné L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46:166–70. https://doi.org/10.1038/ng.2873.

Article  CAS  PubMed  PubMed Central  Google Scholar 

FlowJo™ Software. Version 10.3. Ashland, OR: Becton, Dickinson and Company. 2019.

Ng SY, Brown L, Stevenson K, deSouza T, Aster JC, Louissaint A Jr., et al. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. Blood. 2018;132:935–47. https://doi.org/10.1182/blood-2017-11-818617.

Article  CAS  PubMed  Google Scholar 

Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al. DNMT3A mutations in acute myeloid leukemia. N. Engl J Med. 2010;363:2424–33. https://doi.org/10.1056/NEJMoa1005143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah MY, Licht JD. DNMT3A mutations in acute myeloid leukemia. Nat Genet. 2011;43:289–90. https://doi.org/10.1038/ng0411-289.

Article  CAS  PubMed  Google Scholar 

Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. 2015;126:1741–52. https://doi.org/10.1182/blood-2015-05-644591.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao WQ, Wu F, Zhang W, Chuang SS, Thompson JS, Chen Z, et al. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell. J Pathol. 2020;250:346–57. https://doi.org/10.1002/path.5376.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen TB, Sakata-Yanagimoto M, Asabe Y, Matsubara D, Kano J, Yoshida K, et al. Identification of cell-type-specific mutations in nodal T-cell lymphomas. Blood Cancer J. 2017;7:e516 https://doi.org/10.1038/bcj.2016.122.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scourzic L, Couronné L, Pedersen MT, Della Valle V, Diop M, Mylonas E, et al. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice. Leukemia. 2016;30:1388–98. https://doi.org/10.1038/leu.2016.29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crescenzo R, Abate F, Lasorsa E, Tabbo F, Gaudiano M, Chiesa N, et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 2015;27:516–32. https://doi.org/10.1016/j.ccell.2015.03.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu KT, Kanno Y, Cannons JL, Handon R, Bible P, Elkahloun AG, et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity. 2011;35:622–32. https://doi.org/10.1016/j.immuni.2011.07.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du M-Q, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627–33. https://doi.org/10.1182/blood.V99.2.627.

Article  CAS  PubMed  Google Scholar 

Hippen AA, Falco MM, Weber LM, Erkan EP, Zhang K, Doherty JA, et al. miQC: an adaptive probabilistic framework for quality control of single-cell RNA-sequencing data. PLOS Comput Biol. 2021;17:e1009290 https://doi.org/10.1371/journal.pcbi.1009290.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Na F, Pan X, Chen J, Chen X, Wang M, Chi P, et al. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming. Nat Cancer. 2022;3:753–67. https://doi.org/10.1038/s43018-022-00361-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Chen X, Tan P, Wang Y, Pan X, Lin T, et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell. 2022;40:1044–.e1048. https://doi.org/10.1016/j.ccell.2022.08.010.

Article  CAS  PubMed  Google Scholar 

Pritchett JC, Yang ZZ, Kim HJ, Villasboas JC, Tang X, Jalali S, et al. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia. 2022;36:165–76. https://doi.org/10.1038/s41375-021-01321-2.

Article  CAS  PubMed  Google Scholar 

Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:371–5. https://doi.org/10.1038/ng.2916.

Article  CAS  PubMed  Google Scholar 

Cortes JR, Palomero T. The curious origins of angioimmunoblastic T-cell lymphoma. Curr Opin Hematol. 2016;23:434–43. https://doi.org/10.1097/MOH.0000000000000261.

Article  CAS  PubMed  Google Scholar 

Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120:1466–9. https://doi.org/10.1182/blood-2012-02-408542.

Article  CAS  PubMed  Google Scholar 

Couronné L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl J Med. 2012;366:95–96. https://doi.org/10.1056/NEJMc1111708.

Article  PubMed  Google Scholar 

Fukumoto K, Nguyen TB, Chiba S, Sakata-Yanagimoto M. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma. Cancer Sci. 2018;109:490–6. https://doi.org/10.1111/cas.13393.

Article  CAS  PubMed  Google Scholar 

Li Z, Cai X, Cai CL, Wang J, Zhang W, Petersen BE, et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood. 2011;118:4509–18. https://doi.org/10.1182/blood-2010-12-